Clomid vs Nolvadex in PCT: complete comparison (SERM, efficacy, tolerance)

Key takeaways

  • ●Clomid (clomiphene) = potent SERM, marked LH/FSH restart. Katz 2012: +146% LH and +97% total T in hypogonadics at 25 mg/d.
  • ●Nolvadex (tamoxifen) = mild SERM, marked anti-gynecomastia. Vermeulen 1978: more modest LH elevation but better visual effects.
  • ●Clomid more effective for deep HPG restart post-long cycle. Nolvadex preferred for short cycles or if clomid side effects.
  • ●Clomid side effects: visual disturbances, mood swings. Nolvadex: low thrombotic risk, superior gyno-protection.
Critèreclomidtamoxifen
ClassSERM (clomiphene citrate)SERM (tamoxifen citrate)
Main targetHypothalamus (HPG)Mammary tissue + HPG
LH/FSH restartMarked (+146% LH)Modest (+50-80% LH)
Anti-gynoModerateMarked (reference)
Half-life~5-7 d~5-7 d
Typical dose50/25/25/25 mg40/20/20/20 mg
Visual disturbancesPossible (Purvin 1995)Rare
Mood effectVariable (irritability)Neutral

Quand choisir clomid

Clomid (clomiphene citrate) is the reference SERM for potent HPG axis restart post-cycle. Katz 2012 (RCT in 36 hypogonadic men) demonstrated an average +146% LH and +97% total testosterone elevation at 25 mg/d × 3 months, with effect maintained long-term. Whitten 2006 and Guay 2003 confirm this efficacy in hypogonadic men. Choose it for: (1) a PCT after long injectable cycle (testosterone 12+ weeks) where suppression is deep, (2) a cycle with strong-suppression compounds (nandrolone, trenbolone) requiring robust restart, (3) a user seeking the 'gold standard' PCT of bodybuilding practice since the 1990s. Pharmacological profile: mixture of enclomiphene (60%, anti-estrogen agonist) and zuclomiphene (40%, mild estrogen agonist that can attenuate the effect) isomers. Mechanism: antagonism of hypothalamic estrogen receptor, lifting negative feedback on GnRH → increased LH/FSH pulse → restoration of testicular steroidogenesis. Drawbacks (Purvin 1995, Rahnema 2014): possible visual disturbances (blurred vision, light halo, light hypersensitivity) in 1-5% of users, mood swings, irritability, sometimes marked emotional effects. Typical dose 50/25/25/25 mg over 4 weeks.

Quand choisir tamoxifen

Nolvadex (tamoxifen citrate) is the historical reference SERM for anti-gynecomastia: Vermeulen 1978 documented its use in oligospermic and normal men with marked anti-estrogen effect at mammary level. Jordan 1993 describes its mechanism: complete estrogen antagonist at mammary tissue, partial agonist at the liver (effect on lipids) and uterus (difference from site to site). Choose it for: (1) a PCT after moderate cycle (testosterone 8-10 weeks or oral cycle alone), (2) a preventive or curative gynecomastia treatment during or after cycle, (3) a user sensitive to clomid visual and emotional disturbances. Favorable pharmacological profile: more modest LH/FSH restart effect than clomid but more predictable, superior anti-gyno at mammary tissue, good neuropsychiatric tolerance profile. Drawbacks (Fisher 1998, NSABP P-1 RCT for breast prevention): low documented thrombotic risk in long oncologic use (not significant on short PCT durations 4-6 weeks), possible mild hepatic effect. Typical dose 40/20/20/20 mg over 4 weeks in PCT, 20-40 mg/d in acute gynecomastia treatment.

Combinaison ?

The clomid + nolvadex combo is the standard robust PCT after long cycles or strong-suppression compounds. Classic 'Rahnema 2014' scheme: clomid 50/50/25/25 mg + nolvadex 40/20/20/20 mg over 4 weeks (adding both schedules). Synergistic action: clomid maximizes hypothalamic HPG restart, nolvadex protects mammary tissue and complements the anti-estrogen effect. Always preceded by hCG 1500 IU EOD × 10 days to restart atrophied testicles before the SERM (Coviello 2005: hCG preserves testicular steroidogenesis during central inhibition phase). T total, LH, FSH, E2 panel at W0 (before PCT) then W4 and W8 post-PCT to confirm recovery. If T < 300 ng/dL at W4 post-PCT, extend 2-4 additional weeks. Cumulated side effects: monitor visual disturbances (clomid), mood, libido, breast sensitivity. The combo is more effective than each SERM alone for cycles with deca, tren, or very long cycles. Sample PCT timeline after long testo + deca cycle: W0 last deca injection, W3 last testo injection if cycle ended together, W3-W4 hCG 1500 IU EOD × 5 doses (10 days), W5 SERM start (combo clomid + nolvadex), W9 SERM end, W13 post-PCT panel (T total, LH, FSH, E2), W17 follow-up panel. Independent lab testing for SERM authenticity: clomid market has 20-30% mislabeling per various sources — verify with Janoshik or buy pharma-grade from legitimate sources. Practical taste warning: clomid pills are notoriously bitter — most users mask with food or capsule re-encapsulation. Visual effects monitoring: if blurred vision, light halos, or scotomas develop, switch to nolvadex immediately and consult ophthalmology.

FAQ

Clomid or nolvadex for a first PCT?
Nolvadex for a first short cycle (testosterone 8-10 weeks at 400 mg/week). Better neuropsychiatric tolerance profile, superior anti-gyno, and rare visual effects. Dose 40/20/20/20 mg over 4 weeks. If deep suppression after long cycle or 19-nor compounds (deca, tren), switch to clomid + nolvadex combo for a more robust restart. Choice depends on expected suppression level (short vs long cycle).
Why does clomid cause visual disturbances?
Purvin 1995 documented several cases of ocular toxicity under clomiphene: blurred vision, light halo, light hypersensitivity, sometimes scintillating scotomas. Suspected mechanism: anti-estrogen action on retina and optic nerve, possibly through modulation of retinal estrogen receptors. Typically reversible effects on cessation but concerning signal. Frequency 1-5% of users, more marked at high doses (> 100 mg/d) or prolonged cycles (> 6 weeks). If symptoms: dose reduction or switch to nolvadex.
Do you need to start PCT with hCG?
Yes for long cycles and strong-suppression compounds. Coviello 2005 and Liu 2002 demonstrated that hCG (LH mimetic) restores testicular steroidogenesis and spermatogenesis — useful for restarting atrophied testicles before SERM. Scheme: hCG 1500 IU EOD × 10-14 days in parallel with last cycle week or at PCT start, then SERM (clomid + nolvadex) over the following 4 weeks. For short solo oral cycles, hCG is not essential (less testicular atrophy).
When to start PCT after cycle?
Depends on the long ester used. For testosterone enanthate (half-life 4.5 d), start PCT at 14-16 days after last injection. For cypionate (half-life 8 d) or Sustanon, 16-21 days. For deca-nandrolone (extended kinetics), 21 days minimum. For solo oral cycles, 2-3 days after last intake (short half-life). General rule: 3 half-lives + safety margin to allow the compound to drop sufficiently and the SERM to act effectively on the released HPG axis.
Clomid or enclomiphene?
Enclomiphene is the trans-clomiphene isomer, the main active component of clomid (60% of the mixture) without zuclomiphene (40%, cis isomer with estrogen agonist activity that can attenuate the effect and cause side effects). Pure enclomiphene (Androxal, in clinical development) would offer a better profile: purer HPG restart, fewer residual estrogenic side effects. For practical PCT, clomid remains far more accessible and cheaper. If available, enclomiphene is theoretically superior.
How long does a typical PCT last?
4-6 weeks for the majority of standard cycles. For short oral cycles: 4 weeks suffice. For 10-12 week testo cycles: 4-6 weeks. For cycles with deca, tren, or very long cycles: 6 weeks minimum, sometimes extended to 8 weeks if T total panel < 300 ng/dL at W4 post-PCT. Hormonal panel at W4 and W8 post-PCT guides the decision to extend or stop.
Can you take clomid + nolvadex during the cycle?
Not as PCT, but possible as preventive/curative treatment. During cycle, the SERM cannot restart an HPG axis continually suppressed by exogenous testosterone: it is biologically consumed without effect. However, nolvadex 10-20 mg/d can be used in prevention or treatment of gynecomastia during cycle (blocking the mammary estrogen receptor). Clomid in cycle is rarely useful. Rule: SERM in PCT, AI during cycle if necessary.
What to do if PCT fails?
If T total panel < 300 ng/dL at W6-W8 post-PCT, consider several options (Rahnema 2014, Coward 2013: ASIH). Extend PCT: clomid 25 mg/d × 4 additional weeks + nolvadex 20 mg/d, close monitoring. Resume hCG 1500 IU EOD × 14 days then SERM again. Consult endocrinologist for complete panel (LH, FSH, prolactin, E2, pituitary MRI if necessary). Consider medical TRT if hypogonadism persistent > 6 months (documented ASIH). Avoid resuming an AAS cycle before complete recovery under penalty of perpetuating hypogonadism.